KALVISTA PHARMACEUTICALS INC (KALV)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$189
Reported value
0.0%
Held as options
-182
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $189 | 7 | 0.00% | new | NEW |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-14 | 13G/A | TANG CAPITAL MANAGEMENT, LLCwith 5 co-filers | 0.0% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $189 | 7 | 1 | 0 | 0 | 0.0% |
| Q1 2026 | 183 | $1.5B | 69,170,112 | 36 | 62 | 41 | 4.2% |
| Q4 2025 | 154 | $1.1B | 66,607,652 | 29 | 47 | 47 | 0.6% |
| Q3 2025 | 142 | $738.2M | 58,576,260 | 29 | 48 | 34 | 3.3% |
| Q2 2025 | 136 | $628.1M | 54,452,943 | 26 | 50 | 31 | 2.0% |
| Q1 2025 | 129 | $648.0M | 54,866,891 | 26 | 41 | 35 | 2.2% |
| Q4 2024 | 125 | $468.3M | 55,202,918 | 20 | 46 | 29 | 0.2% |
| Q3 2024 | 116 | $569.0M | 48,487,268 | 15 | 46 | 29 | 1.3% |
| Q2 2024 | 116 | $569.4M | 48,274,381 | 16 | 43 | 31 | 0.1% |
| Q1 2024 | 122 | $573.2M | 47,672,802 | 44 | 29 | 31 | 1.4% |
| Q4 2023 | 94 | $479.4M | 37,298,886 | 10 | 44 | 18 | 4.7% |
| Q3 2023 | 96 | $361.6M | 36,051,051 | 20 | 31 | 24 | 4.1% |
| Q2 2023 | 86 | $293.8M | 32,487,488 | 16 | 31 | 16 | 0.6% |
| Q1 2023 | 74 | $248.5M | 31,644,689 | 14 | 20 | 21 | 0.0% |
| Q4 2022 | 74 | $212.7M | 31,603,836 | 18 | 19 | 19 | 0.2% |
| Q3 2022 | 94 | $381.9M | 25,639,577 | 17 | 25 | 30 | 2.6% |
| Q2 2022 | 87 | $244.6M | 24,253,337 | 17 | 35 | 21 | 2.5% |
| Q1 2022 | 87 | $365.7M | 24,343,746 | 9 | 32 | 28 | 0.5% |
| Q4 2021 | 95 | $315.8M | 23,843,619 | 10 | 33 | 26 | 0.1% |
| Q3 2021 | 105 | $412.3M | 23,381,061 | 16 | 33 | 29 | 1.0% |
| Q2 2021 | 111 | $590.2M | 24,320,508 | 18 | 38 | 38 | 1.3% |
| Q1 2021 | 118 | $617.0M | 23,587,958 | 53 | 43 | 16 | 1.9% |
| Q4 2020 | 83 | $321.7M | 16,460,979 | 30 | 21 | 23 | 5.0% |
| Q3 2020 | 61 | $203.9M | 16,200,853 | 3 | 22 | 18 | 0.0% |
| Q2 2020 | 72 | $193.7M | 15,986,858 | 14 | 24 | 17 | 0.0% |
| Q1 2020 | 68 | $121.8M | 15,926,656 | 10 | 24 | 20 | 0.0% |
| Q4 2019 | 73 | $247.3M | 13,885,674 | 17 | 27 | 15 | 0.0% |
| Q3 2019 | 76 | $159.3M | 13,729,186 | 15 | 21 | 19 | 0.0% |
| Q2 2019 | 75 | $328.5M | 14,832,582 | 24 | 21 | 17 | 0.0% |
| Q1 2019 | 68 | $398.9M | 13,941,485 | 17 | 17 | 16 | 0.0% |
| Q4 2018 | 57 | $263.0M | 13,399,191 | 1 | 1 | 2 | 0.0% |